Regeneron Pharmaceuticals, Inc. (BVMF:REGN34)
Brazil · Delayed Price · Currency is BRL 72.30
-0.30 (-0.41%)
At close: Dec 23, 2025
Regeneron Pharmaceuticals Market Cap
Regeneron Pharmaceuticals has a market cap or net worth of 443.9 billion as of December 24, 2025. Its market cap has decreased by -13.67% in one year.
Market Cap
443.90B
Enterprise Value
355.44B
Revenue
75.93B
Ranking
n/a
PE Ratio
18.19
Stock Price
72.30
Market Cap Chart
Since July 20, 1992, Regeneron Pharmaceuticals's market cap has increased from 177.17M to 443.90B, an increase of 250,456.74%. That is a compound annual growth rate of 26.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 443.90B | -6.35% |
| Dec 31, 2024 | 474.01B | 4.59% |
| Dec 29, 2023 | 453.22B | 11.26% |
| Dec 30, 2022 | 407.37B | 10.73% |
| Dec 31, 2021 | 367.89B | 38.93% |
| Dec 31, 2020 | 264.80B | 60.49% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rede D'Or São Luiz | 89.22B |
| Raia Drogasil | 39.93B |
| Hypera | 14.42B |
| Fleury | 7.98B |
| Odontoprev | 5.89B |
| Diagnósticos da América | 5.14B |
| Empreendimentos Pague Menos | 3.89B |
| Oncoclínicas do Brasil Serviços Médicos | 3.22B |